DE-ESCALATION OF BREAST CANCER TREATMENTS ORGANISED BY EORTC AND BIG
DE-ESCALATION OF BREAST CANCER TREATMENTS ORGANISED BY EORTC AND BIG
Time Zone:
Europe/Paris GMT+2
Institution:
EORTC, BIG
previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES
Moderator:
Speakers:
Theme :
Language:
Etienne Brain, David Cameron, Boon Chua, Fatima Cardoso, Elizabeth Bergsten Nordstrom
Brief introduction on global breast cancer research and de-escalation of breast cancer treatments, Brief presentation of DECRESCENDO study and introduction of the speakers, Tailoring radio therapy after surgery to an individual patient’s risk of recurrence (EXPERT study – BIG Radio Tuning). Tailoring radiation dose escalation after surgery: cosmetic results and patient reported outcomes informing treatment decision-making (DCIS study), Using the biological characteristics of a tumour and novel diagnostic tests to help safely exclude chemotherapy (MINDACT study), Getting the patient’s perspective: Importance of giving patients the right information about de-escalation risks, Q&A session
Inglês

Programme

 

13:00-13:05 Brief introduction on global breast cancer research and de-escalation of breast cancer treatments – Prof. Etienne Brain, EORTC Breast Cancer Group Chair & BIG Executive Board member

13:05-13:10 Brief presentation of DECRESCENDO study and introduction of the speakers – Prof. David Cameron, BIG Chair and EORTC Breast Cancer Group member

13:10-13:25 Tailoring radio therapy after surgery to an individual patient’s risk of recurrence (EXPERT study – BIG Radio Tuning). Tailoring radiation dose escalation after surgery: cosmetic results and patient reported outcomes informing treatment decision-making (DCIS study) – Prof. Boon Chua, BIG Executive Board member & Study Principal Investigator of EXPERT and DCIS

13:25-13:35 Using the biological characteristics of a tumour and novel diagnostic tests to help safely exclude chemotherapy (MINDACT study) – Prof. Fatima Cardoso, EORTC Breast Cancer Group and BIG member & Study Principal Investigator of MINDACT

13:35-13:45 Getting the patient’s perspective: Importance of giving patients the right information about de-escalation risks – Mrs Elizabeth Bergsten Nordstrom, EUROPA DONNA Executive Board member

13:45-14:00 Q&A session

Download the Agenda

Search for our next event. See you soon!

Subscribe to get news on all upcoming events

who%20goals_edited.png

DocMeeetings

Social Media

  • Twitter DocMeetings
  • Instagram DocMeetings
  • Facebook ícone social
  • LinkedIn ícone social

contact us

Adress

Sao Paulo, SP - Brazil

© 2020 by Docmeetings - A DocMeetings.com Company
Site Managed by:
QUALITY Soluções Web
1996-2020 "24 years inspiring technology"